Last deal

$5.4M

Amount

Debt Financing

Stage

12.11.2020

Date

11

all rounds

$112.9M

Total amount

General

About Company
ALung Technologies is a medical device manufacturing company that develops gas exchange devices for respiratory disorders.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.1997

Number of employees

Company Type

For Profit

Last funding type

Debt Financing

IPO status

Private

Description

The company's technology includes Hemolung, an extracorporeal gas exchange device that circulates blood through a small catheter, and Hattler Catheter, which is placed within the central venous bloodstream. Their Hemolung Respiratory Assist System (RAS) is a dialysis-like alternative to mechanical ventilation that removes carbon dioxide from the blood, allowing the patient's lungs to rest and heal. ALung Technologies was founded in 1997 and is headquartered in Pittsburgh, Pennsylvania. They are now part of LivaNova.
Contacts

Social url